检索结果 - Christopher Short
- Showing 1 - 4 results of 4
-
1
-
2
-
3
-
4
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic... 由 Jane C. Davies, Isabelle Sermet‐Gaudelus, Lutz Naehrlich, R. Scott Harris, Daniel Campbell, Neil Ahluwalia, Christopher Short, Eric L. Haseltine, Paul Panorchan, Clare Saunders, Caroline A. Owen, Claire Wainwright
出版 2020Artigo
相关主题
Medicine
Cystic fibrosis
Internal medicine
Biology
Engineering
Intensive care medicine
Adverse effect
Alternative medicine
Chronic rhinosinusitis
Criminology
Cystic fibrosis transmembrane conductance regulator
Discontinuation
Economic Justice
Engineering ethics
Ivacaftor
Law
Limiting
Mechanical engineering
Neuroscience
Nursing
Olfaction
Paleontology
Pathology
Placebo
Political science
Psychology
Quality of life (healthcare)
Sociology
Test (biology)
Washout